As the COVID-19 situation continues to evolve, we want to assure all our customers and patients that we remain, as ever, committed to supporting patients to access the medicines they need and partnering with the NHS and HSE to deliver the best care to those who need it. We have already taken several measures to protect the health and wellbeing of our staff so that we can continue to deliver for our patients during these unprecedented times.
We recommend that all patients using Amgen medicines who have questions or concerns about their treatment plan seek advice from their doctor.
For general information specific to a product, please click here.
Supply of our Medicines
We will continue to do everything in our power to provide an uninterrupted supply of medicines for patients around the world. Based on inventory levels, we do not anticipate a shortage of our medicines due to COVID-19 in the UK and Ireland at this time. However, we recognise this is a highly dynamic situation and are working with our partners throughout the supply chain to anticipate and mitigate risk wherever possible.
Effective Monday, March 16, in line with government guidance in both the UK and Ireland, we have advised all staff members who can work from home to do so until further notice.
Since then we have made the decision to suspend all face-to-face visits to our NHS partners and customers, however we are well equipped to engage with customers virtually to help support with their needs. We believe this approach will support efforts to delay the spread of COVID-19 and support our health and care professionals and the wider health system to focus on dealing with identifying and treating patients affected by the disease.
In line with government measures we have suspended business travel and attendance at medical congresses, conferences and other large events through to May 17.